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Deep brain stimulation (DBS), a surgical technique to treat certain neurologic and
psychiatric conditions, relies on pre-determined stimulation parameters in an open-loop
configuration. The major advancement in DBS devices is a closed-loop system
that uses neurophysiologic feedback to dynamically adjust stimulation frequency and
amplitude. Stimulation-driven neurochemical release can be measured by fast-scan
cyclic voltammetry (FSCV), but existing FSCV electrodes rely on carbon fiber, which
degrades quickly during use and is therefore unsuitable for chronic neurochemical
recording. To address this issue, we developed durable, synthetic boron-doped
diamond-based electrodes capable of measuring neurochemical release in humans.
Compared to carbon fiber electrodes, they were more than two orders-of-magnitude
more physically-robust and demonstrated longevity in vitrowithout deterioration. Applied
for the first time in humans, diamond electrode recordings from thalamic targets
in patients (n = 4) undergoing DBS for tremor produced signals consistent with
adenosine release at a sensitivity comparable to carbon fiber electrodes. (Clinical trials #
NCT01705301).
Keywords: diamond-based electrode, dopamine, deep brain stimulation (DBS), fast scan cyclic voltammetry
(FSCV), carbon fiber microelectrode, neuromodulation
INTRODUCTION
Deep brain stimulation (DBS) is used to treat a number of debilitating neurologic and
neuropsychiatric disorders such as essential tremor, Parkinson’s disease, and depression, which are
linked to abnormal extracellular neurochemical concentrations (Burns et al., 1985; Sarter et al.,
2007). DBS is thought to regulate or control neurochemical release (Lee et al., 2004, 2006, 2007;
Bekar et al., 2008; Navailles et al., 2010; Shon et al., 2010b; Meng et al., 2011), but existing DBS
devices depend on pre-programmed electrical stimulation amplitude and frequency in an open-
loop configuration. To improve outcomes and reduce adverse effects, the goal of current research
is an implantable closed-loop “smart” device that uses neurochemical feedback to drive stimulation
parameters (Lee et al., 2009).
As a first step toward this goal, we created the Wireless Instantaneous Neurochemical
Concentration Sensing (WINCS) system, a wireless, real-time, in vivo neurochemical monitoring
system (Agnesi et al., 2009; Bledsoe et al., 2009; Shon et al., 2010a), which we have shown to
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be capable of monitoring neurochemical release during human
DBS surgery using carbon fiber microelectrodes (CFMs) (Chang
et al., 2012b). WINCS uses fast-scan cyclic voltammetry (FSCV),
a well-established electroanalytical technique that can detect and
measure neurochemicals in vitro (Rice et al., 1997; Cragg et al.,
2000; Staal et al., 2004; Adams et al., 2008) and in vivo (Garris
et al., 1999; Phillips et al., 2003; Robinson et al., 2003; Suaud-
Chagny, 2004; Dommett et al., 2005; Swamy and Venton, 2007;
Hashemi et al., 2009) by imposing a voltage waveform that ramps
through the oxidation and reduction potentials of the species of
interest while monitoring the nanoampere scale electrical current
that is generated by redox reactions at specific voltages.
The integration of WINCS with a neurochemical sensing
microelectrode coupled with a feedback control algorithm could
serve as the foundation for a chronically implantable closed-loop
DBS device. However, for such a device to be clinically useful,
implanted recording electrodes must be both mechanically and
electrochemically stable over the life-time of the patient. In this
regard, CFMs represent a major obstacle.
Widely used with FSCV, CFMs have high sensitivity to several
important neurochemicals (Cahill et al., 1996; Wightman and
Robinson, 2002), fast electron-transfer kinetics (Roberts et al.,
2010), relatively simple surface chemistry (McCreery et al., 1995),
and low cost. At the same time, they suffer from extreme
mechanical fragility, surface fouling, and a relatively small
voltage range or “faradaic window” within which measurements
can be made. Outside this range, water is electrolyzed into
gaseous hydrogen and oxygen, preventing the detection and
measurement of other compounds and rapidly destroying the
electrode and surrounding tissue.
When subjected to an FSCV waveform (−0.4V to +1.3V
vs. Ag/AgCl at 400V/s) for an extended period of time, CFMs
have been found to erode (Takmakov et al., 2010) and their
mechanical integrity is eventually compromised (Keithley et al.,
2011). Takmakov et al. (Takmakov et al., 2010) postulated that
carbon over-oxidation causes mechanical failure via formation of
carboxylic groups at the carbon surface with further oxidation
through electrolysis. This leads to the generation of carbon
dioxide (Takmakov et al., 2010) which dissolves in the interstitial
liquid and is ultimately dispersed. Thus, extended imposition of
the FSCV waveform will permanently degrade CFMs, precluding
their use in chronic human implants.
Boron-doped diamond microelectrodes represent an
alternative and have been developed for neurochemical detection
in vitro (Park et al., 2005; Halpern et al., 2006; Xie et al., 2006;
Patel et al., 2007; Bitziou et al., 2008; Marcelli and Patel, 2010;
Singh et al., 2010; Zhao et al., 2010) and in vivo (Suzuki et al.,
2007; Chan et al., 2009; Yoshimi et al., 2011). To-date, they
have been used to: record dopamine release from the corpus
striatum of the mouse brain following electrical stimulation
of the medial forebrain bundle (Suzuki et al., 2007); monitor
dopamine transients in response to a reward cue in the striatum
of the non-human primate (Yoshimi et al., 2011); measure
norepinephrine release from the sympathetic nervous system of
the rat (Park et al., 2005); show important differences in brain
serotonin transport function associated with genetic variability
in non-human primate lymphocytes (Singh et al., 2010); and
examine pharmacologically induced adenosine release from rat
brain slices (Xie et al., 2006). Boron-doped diamond electrodes
in these applications demonstrated excellent electrochemical
properties, including a wide potential window, low baseline
current, and excellent stability. However, none of these studies
used FSCV, nor did they investigate the efficacy of diamond
electrodes in human patients—a critical goal for their application
in closed-loop DBS therapy.
To that end, we developed boron-doped diamond
microelectrodes and tested their performance for real-time
detection of neurochemical release using WINCS-based FSCV,
both in vitro (to illustrate longevity) and in vivo (to illustrate
efficacy) in human patients undergoing DBS surgery for tremor
from either Parkinson’s disease or essential tremor. Prior to
therapeutic DBS lead placement and depending on the target
of interest, an experimental diamond electrode was placed in
either the ventral intermediate (VIM) nucleus of the thalamus
or the subthalamic nucleus (STN), and mechanically-evoked
neurochemical release was observed.
Comparing these results with the performance of CFMs, we
found that while both types of electrodes demonstrate good
sensitivity in detecting neurochemicals in vitro and in vivo,
boron-doped diamond electrodes have increased longevity
and mechanical strength, critical characteristics for reliable
and safe use in vivo. Our results suggest that boron-doped
diamond electrodes may be the solution for chronic implantation
which could support basic research investigating long-term
neurochemical responses in animals, and in humans, it could
potentially “close the loop” in DBS.
RESULTS
These studies were approved by Mayo Clinic IRB (IRB #09-
007441) and registered with ClinicalTrials.gov (Clinical trials #
NCT01705301).
Diamond Electrode Characterization
The electrodes used in this study were prepared by depositing
films of polycrystalline boron-doped diamond on conically-
sharpened tungsten rods using chemical vapor deposition
(CVD). Electrodes were prepared in batches of 8 (as this is
what the CVD reactor is designed to accommodate), and
up to one batch per day was produced. Thus far, our lab
has produced and characterized in excess of 500 diamond-
coated electrodes. The resulting boron-doped diamond
electrode tips were characterized by scanning electron
microscope (SEM) (all batches) and Raman spectroscopy
(select batches).
Imagery depicting an example electrode is illustrated in
Figure 1. The boron-doped diamond films were polycrystalline,
with average crystal dimension within the range of 0.5–2µm
and a film thickness of approximately 5–10µm. Both (1 1 1)
and (1 1 0) orientations were observed. The diameter of the
conical electrode tips was approximately 50µm, and the exposed
length around 100µm for a total (geometric) surface area of
approximately 10,000µm2. Figure 1 provides more details of
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FIGURE 1 | Diamond FSCV probe construction. Panel (A) depicts the overall full length electrode suitable for acute large animal and human recordings. The scale
bar is 25mm. Panel (B) shows a detailed optical magnification of the tip and its individual components, scale bar is 500µm. Panel (C) is an SEM image, showing the
transition from the parylene insulation to the diamond sensing tip, scale bar is 100µm (crystal detail scale bar is 10µm). Panels (D,E) show Raman spectral maps of
the probe depicted in panel (C), scale bar is 10µm. The three color channels assigned to material constituents are: blue for boron doped diamond, red for diamond,
and green for carbon sp2 impurities. Magenta color observed in image (D) is a combination of blue and red. Panel (F) shows the integrated Raman spectrum of
Raman images in panels (D,E). The Raman measurements were acquired with a 532 nm excitation source.
the electrode tip and parylene insulation layer/diamond film
interface.
To allow visual determination ofmaterial constituents, Raman
microscopy was performed at the electrode tip. The results
are presented in Figures 1D,E. The dominant magenta color
resulting from a combination of blue (assigned to boron)
and red (assigned to diamond) that is observed in Figure 1D,
demonstrates a relatively uniform incorporation of boron
into diamond. As diamond is composed of carbon atoms
exclusively bonded to each other by sp3-hybridized orbitals, its
characteristic Raman spectrum is a single peak at 1332 cm−1.
Besides the existence of this sharp peak, the integrated Raman
spectrum of Figures 1D,E, presented in Figure 1F, reveals other
less intense bands. The broader band around 1500 cm1 is
attributed to existence of a small amount of carbon sp2. The
weak features around 1230 cm−1 and 550 cm−1 correlate with
boron incorporation and accumulation in the diamond lattice,
respectively (Bernard et al., 2004). These data confirm that
the diamond-like crystal morphology observed in the SEM
imagery does, indeed, correspond to boron-doped polycrystalline
diamond.
Electrode Sensitivity and Longevity
First, any prospective FSCV electrode must produce a
voltammogram with distinct signatures that correspond to
analytes of interest (specificity). For instance, both dopamine
and adenosine may be encountered in the thalamus—a common
DBS target—and the electrode must be able to separate their
signatures. Toward this end, dopamine, adenosine, and a
combination of the two were presented to a diamond electrode
in a flow cell. As illustrated in Figure 2, their oxidation and
reduction signatures are quite distinct, and a combination of the
two analytes produces a voltammogram that is a simple linear
addition of the individual voltammograms.
While the in vivo data presented in this work are acute (no
more than 30min per patient were allowed by the IRB-approved
experimental protocol), the motivation for moving from carbon
fiber to diamond is the promise of vastly-improved longevity
sufficient for chronic implantation. Two metrics are of crucial
importance in the construction of any electrode destined for
chronic in vivo implantation: sensitivity of the electrode to the
analyte(s) of interest, and the ability of the electrode to maintain
that sensitivity after extended continuous use.
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FIGURE 2 | Diamond FSCV probe exposed to dopamine at 2.5µM (A), adenosine at 20µM (B), and dopamine + adenosine at the same concentrations
(C). Note that the signals of the two neurotransmitters occur at different voltages and are effectively additive. That is, the voltammogram of dopamine + adenosine is a
linear combination of the voltammograms of the two individual neurotransmitters.
To test these metrics, dopamine was selected as the test
analyte for these in vitro studies, as the dopamine oxidation
and reduction responses at CFMs using FSCV have been well
characterized (Robinson et al., 2003). Newly-fabricated diamond
electrodes were imaged with a SEM and calibrated by subjecting
them to dopamine in flowing Tris buffer while applying the
FSCV voltage waveform described in the Methods section. After
calibration with dopamine, the electrodes were transferred to a
bath of pure Tris buffer where the FSCV waveform was applied
continuously for an extended period of time. CFMs (a current
standard for FSCV use) were subjected to identical treatment
as a control. After 72 and 144 h of continuous use at these
conditions, both types of electrodes were removed from the
buffer and recalibrated. After the conclusion of the experiment,
scanning electron micrographs were obtained. The results of the
corresponding calibrations are depicted in Figure 3.
Throughout the course of the experiment, the sensitivity
decreased for both the diamond and the CFMs. The diamond film
electrode average dopamine sensitivity (nA/µM) decreased 6.7%
from t = 0 to t = 72 h (Figure 3H; 95% confidence interval
[CI]: –3.6 to 15.8%), and 16.1% from t = 0 h to t = 144 h
(Figure 3I; 95% CI: 7.8 to 23.4%). In contrast with the stability
demonstrated by the diamond electrode, the CFM’s calibration
curve revealed marked degradation in sensitivity after 24 h. The
CFM average dopamine sensitivity decreased 43.4% from t = 0
to t = 72 h (Figure 3H; 95% CI: 37.5 to 48.9%) and 89.4%
from t = 0 h to t = 144 h (Figure 3I; 95% CI: 88.6 to 90.2%).
After 144 h of use—5.2 million measurement cycles—the CFM
had become, in effect, completely insensitive to dopamine and
the calibration experiment was discontinued, while the diamond
electrode retained 83.9% of its initial sensitivity.
After 3 and 6 (total) days of continuous use, both types of
electrodes were subjected to imaging by SEM. The resulting
SEM imagery is presented in Figures 3A–F. While the diamond
electrode showed no discernible changes, the CFM had been
almost completely eroded. Given the chemical simplicity of
the buffer solution, this erosion is most likely due to physical
dissolution of the electrode tip by electrolysis reactions at the
electrode surface:
C+ 2H2O→ CO2 + 4H
+ + 4e−and/or
C+H2O→ CO+ 2H
+ + 2e−
during the period of the FSCV waveform where the CFM is
acting as the anode (positive polarity) with a voltage in excess
of 1.2–1.4 volts. While diamond is also an allotrope of carbon,
the higher degree of covalent bonding likely leads to the above
reactions occurring at much slower rates (though degradation is
still thermodynamically favorable).
Physical Robustness
Another critical property of any electrode intended for human
surgical use is its physical robustness with respect to mechanical
damage. While electrochemical durability in a flow cell is a
necessary first step to a practical electrode design, the final
electrode must resist forces stronger than those exerted by tissue
resistance during implantation. The tissue of the living brain,
while one of the softest tissues in the body, is still firm enough
to break a single carbon fiber.
To quantify their relative resilience, both electrode designs
were slowly forced into a stainless steel plate while the
displacement distance and exerted force were simultaneously
recorded. Both electrodes deformed by approximately
100–120µm before failing; however the failure modes were
very different. The CFM exerted a fairly constant force of about
0.1–0.15 g against the plate as the carbon filament at the tip slowly
bowed outwards. When the carbon fiber could bend no further,
it snapped, and the force against the plate was reduced to zero.
The diamond-coated tungsten electrode tip, by comparison,
did not break at any point. Rather, it slowly deformed as the sharp
tip bent to one side and curled back on itself. Even after exerting
30–40 g of force (approximately 200 timesmore force than caused
the CFM to fail), the diamond electrode remained largely intact.
Both electrodes were examined by SEM following the test, and the
only apparent damage to the diamond electrode was some loss of
the diamond coating where the bending of the tungsten substrate
occurred. The carbon fiber electrode, by contrast, was destroyed.
Diamond Electrode Sensitivity In vivo
The results obtained regarding electrode longevity and strength
strongly suggest that diamond electrodes would be superior
for chronic implantation as required for FSCV sensing in an
implantable closed-loop DBS system. Following these in vitro
trials, a series of animal trials were conducted in both small
(Rattus norvegicus) and large (Sus scrofa) animals to determine
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FIGURE 3 | SEM images of diamond electrode (A–C) and carbon fiber electrode (D–F). Panels (A,D) are at t = 0, panels (B,E) t = 72 h, and panels (C,F) are at
t = 144 h. Panels (G–I) show diamond and carbon fiber calibration curves for the detection of dopamine at t = 0 h (G), t = 72 h (H), and t = 144 h (I) of continuous use.
in vivo efficacy. However, to demonstrate the efficacy of diamond
electrodes for their intended application, volunteer test subjects
were recruited from among patients undergoing DBS lead
placement surgery for tremor disorders (Parkinson’s disease and
essential tremor).
In order to minimize risk to the patients, only one parallel
surgical trajectory was permitted by the IRB-approved protocol,
chosen solely based on the needs of the patients’ intended DBS
therapy. In patients selected for these studies, the therapeutic
DBS lead—a standard 4-contact leadmanufactured byMedtronic
(model 3387 or 3389)—was targeted at the VIM nucleus of
the thalamus (n = 3) or the STN (n = 1). The diamond
electrode was inserted into the target region first, prior to the
therapeutic DBS electrode, and mechanically-stimulated release
of the neurochemical adenosine due to the “microthalamotomy”
effect (Chang et al., 2012b) was observed, as depicted in
Figure 4. Although dopaminergic neurons have been shown to
innervate parts of the non-human primate and human thalamus
(principally dorsal aspects), only adenosine release was observed.
This was likely due to the specific region of the thalamus targeted
for DBS which has been shown to contain a relatively small
number of dopaminergic terminals (Sanchez-Gonzalez et al.,
2005) (targeting information is provided in the Supplementary
Materials).
In these experiments in humans (and in swine) an adenosine-
like signature secondary to mechanical stimulation was observed,
with oxidation peaks around 1.5V and 1.0V. The additional
signature around 0.5V ismost likely due to a local change in pH—
a known effect in FSCV recordings using CFMs (Runnels et al.,
1999). This represents the first application of FSCV via diamond-
based electrodes in human subjects and verifies the diamond
electrode’s ability to sense evoked changes in the extracellular
levels of neurochemicals in the human brain. Previously, our
laboratory also conducted a very similar series of experiments
using CFMs in human subjects (Chang et al., 2012b). These
experiments, conducted using the same protocol as the diamond
experiments, also detected adenosine-like signatures secondary
to mechanical stimulation, as depicted in Figure 5.
Figure 5C depicts mechanical stimulation of an adenosine-
like species in the VIM of an awake human patient using
a traditional CFM. This patient was undergoing DBS lead
placement surgery for Parkinson’s disease. Figure 5D depicts an
identical experiment (same target, same protocol) conducted in
a different patient using a diamond electrode. The biochemical
milieu of the human brain is far more complex than the pure
adenosine present in a flow cell. However, the signature oxidation
peak at the potential of +1.5V is highly consistent with adenosine
oxidation and was present in all cases. In the various panels of
Figure 5, it is clear that the diamond electrode is less sensitive
to the second oxidation peak of adenosine (around 1.0V) than
carbon fiber. The diamond electrodes are also less sensitive to the
broad feature associated with pH change located around 0.5V.
However, given that the relative strength of the various oxidation
peaks for adenosine oxidation products is variable even between
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FIGURE 4 | Diamond electrode performance in vitro and in vivo. Panel (A) depicts a diamond electrode’s response to identical in vitro conditions. Panel (B)
depicts the same diamond electrode in the ventral lateral thalamus of an anesthetized pig, where an adenosine-like signature secondary to mechanical stimulation
was observed. Panel (C) depicts the same electrode in the subthalamic nucleus of an awake human undergoing DBS lead-placement surgery for essential tremor
(prior to the DBS lead placement). In panels (B,C), the signature is consistent with adenosine based on the oxidation peaks near the switching potential at 1.5 V. All
“diamond” data was recorded with the same specific electrode (although not in the order shown—the human data were always gathered first).
different grades of carbon fiber (Swamy and Venton, 2007), the
fact that there is some difference in behavior between carbon fiber
and diamond—two entirely different carbon allotropes—is not
surprising.
Human test subjects are ideal in the sense that they are
the ultimate intended environment for a chronic sensing
electrode for a closed-loop DBS system, however human trials
do present some unique challenges. These challenges include
the inability to pharmacologically-manipulate neurotransmitter
levels, the short duration of recording that is possible, and
a surgical trajectory that is defined and limited by the needs
of the therapeutic procedure the patient is undergoing. All
study patients were equipped with a hand-mounted wireless
accelerometer. In the case of a representative patient depicted
in Figure 6 (essential tremor, lead placement in the VIM),
the mechanically-evoked release of the neurochemical
adenosine (“microthalamotomy effect”) caused by lead
placement was sufficient to produce an almost complete
cessation in the patient’s tremor. Prior to lead placement,
this patient exhibited a strong tremor at 4.2Hz as shown in
Figures 6D,F, while this tremor is absent post-placement in
Figures 6E,G.
This effect is common in human patients, even without
an electrical current being applied to a stimulating electrode.
The mechanical effect of lead placement alone is sufficient
to ameliorate tremor. As depicted in Figures 4, 5, mechanical
advancement of the electrode is also associated with adenosine-
like signals detectable by FSCV.While this link is not sufficient to
draw conclusions vis-à-vis mechanism, it does demonstrate that
the adenosine-like signals accessible to a diamond electrode are
related to the desired clinical outcome of tremor-reduction—a
necessary condition for closed-loop DBS.
DISCUSSION
It has been demonstrated that a CVD diamond reactor has
the ability to deposit films of high quality boron-doped
polycrystalline diamond on tungsten electrode substrates. These
diamond-coated tungsten needles can be employed to create
durable and sensitive electrodes for FSCV.
After fabrication, these diamond-coated tungsten needles
form complete electrodes useful for electrochemical detection
of neurochemicals. Furthermore, these diamond electrodes, in
conjunction with WINCS-based systems (Agnesi et al., 2009;
Bledsoe et al., 2009; Shon et al., 2010a), are capable of detecting
changes in extracellular concentrations of neurochemicals. Their
ability to sense neurochemicals was verified with in vivo detection
of adenosine-like signals in either the VIM nucleus of the
thalamus or the STN of human patients undergoing DBS lead-
placement surgery, comporting well with the findings of Chang
et al. (2012b).
The FSCV sensing lifetime of diamond-based electrodes is
dramatically superior to the lifetime of the current standard
CFMs, showing little degradation over 5.2 million cycles (144 h at
10Hz), while a CFMwas eroded and rendered almost completely
insensitive under the same conditions. If this was a chronic
implant, 5.2 million scans would be roughly equivalent to 1
scan every 2min for 20 years. While additional degradation or
desensitization mechanisms could affect both electrodes in vivo,
the electrochemical degradation seen here would certainly render
carbon fiber unusable over this timespan.
In addition, the diamond electrode design exhibited a greater
than 2 order-of-magnitude improvement in physical robustness
with respect to mechanical damage of the tip. This robustness
is critical for eventual chronic human application. Given the
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FIGURE 5 | Comparison of diamond electrode (the same electrode
depicted in Figure 4) with a carbon fiber electrode in a flow cell and
in vivo in the ventral intermediate (VIM) nucleus of the thalamus in a
human patient. In both in vivo cases, neurotransmitter release was evoked
by mechanical stimulation (“microthalamotomy” effect) and showed an
adenosine-like signal. (A) Carbon fiber electrode in vitro; (B) Diamond
electrode in vitro; (C) Carbon fiber electrode in vivo (human); (D) Diamond
electrode in vivo (human).
softness of brain tissue and the small diameter of the carbon fiber
(on the order of 10µm), even the 0.1–0.15 g of insertion force
that the carbon fiber electrodes withstood will often be sufficient
for acute experiments. Still, reliable use of such delicate electrodes
demands precise assembly and tolerates almost no asymmetry
in the application of force (i.e., insertion must be straight into
the brain with no lateral forces). The stronger diamond-based
electrodes are far more forgiving.
For either basic science studies of long-term neurochemical
release in the brain, or the eventual construction of a closed-
loop DBS device, a long-lived sensing electrode is required.
Full realization of a practical closed-loop DBS system will
still require additional work. First, these sensing tips must be
incorporated into a flexible and implantable lead that mates with
an appropriate electronics package, not unlike the Medtronic
3387/3389 DBS electrodes mate with their “Activa” series of
implantable pulse generators. Such leads are currently being
designed in our laboratory.
Next, a pulse generator must be constructed that is capable
of producing and analyzing the FSCV waveform. Mayo Clinic
has already designed and tested such a device (“WINCS”) along
with a mating DBS stimulator (“MINCS”) (Chang et al., 2012a),
and it is this WINCS device that was used to gather the data
presented in this study. A second generation non-implantable but
fully integrated FSCV/DBS device (sensing and stimulation) has
also been constructed within our laboratory, and prototypes are
currently undergoing testing at Mayo Clinic. A third generation
of fully-implantable FSCV/DBS stimulators will also need to
be developed before neurotransmitter-based feedback can be
clinically useful. Design of this 3rd-generation implantable
device will depend on data gathered with the non-implantable
version, as implantability imposes significant constraints on size,
reliability, and power consumption.
Finally, a control algorithm that can use FSCV-measured
neurotransmitter concentration data to control DBS stimulation
parameters in order tomaintain a set neurotransmitter level must
be designed. This algorithm is also under development within
the Mayo Clinic Neural Engineering Lab. All of these elements
must come together to enable a clinically-useful closed-loop DBS
device based on neurotransmitter concentration sensing, but
prior to this study there existed no obvious solution to the need
for a durable, safe, and effective human FSCV electrode.
While CFMs provided excellent sensitivity for intraoperative
use, their mechanical fragility complicated the surgery, and
their electrochemical instability over time would never allow
for the possibility of chronic implantation. By comparison,
the properties of diamond-based electrodes largely overcome
mechanical issues, while their electrochemical characteristics
offer significant potential for chronic recordings in vivo.
Furthermore, the correlation between observed tremor reduction
and adenosine-like FSCV signature at the diamond electrode
suggests that an FSCV-based closed-loop DBS system may well
be within the reach of practical implementation.
MATERIALS AND METHODS
Chemicals
Chemicals were acquired from Sigma-Aldrich (St Louis, MO),
and were used as received. All solutions were made using
deionized (DI) water. Flow cell experiments were conducted
in Tris buffer (150mM sodium chloride and 12mM Tris, pH
adjusted to 7.4 with concentrated sodium hydroxide solution).
For flow cell injection, 5mM dopamine stock solution was
prepared in DI water, and diluted to desired concentration in Tris
buffer.
Electrode Fabrication
Both boron-doped diamond and CFMs were utilized in this
study. To prepare boron-doped diamond microelectrodes,
boron and carbon were co-deposited to form diamond
films on tungsten wires (250µm in diameter, A-M systems,
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FIGURE 6 | Intraoperative tremor recordings before and after DBS lead placement. This patient underwent DBS lead placement for essential tremor, with the
diamond-based electrode placed in the ventral intermediate (VIM) nucleus of the thalamus prior to therapeutic DBS lead placement (top panels A–C). Throughout the
surgery, the patient wore a hand-mounted wireless accelerometer to measure tremor. Prior to surgery, the patient displayed a pronounced tremor at 4.2Hz (left
panels, D,F), while after lead placement the mechanical stimulation alone (“microthalamotomy” effect) caused a cessation of this tremor with no applied voltage (right
panels, E,G).
Carlsborg, WA) using custom developed, hot-filament CVD
techniques. The source gas was 1% methane in hydrogen with
trimethylborane (1000 ppm in hydrogen) as the boron dopant
source. The CVD reactor filament temperature was nominally
maintained at 2000◦C and the total pressure at 20 torr. Prior
to CVD processing, the tungsten wires were electrochemically
etched in 1M sodium hydroxide by applying 10V AC voltage
to create a tapered sharpened tip. The generated tungsten tips
were sonicated with 100 nm diamond particles suspended in
isopropyl alcohol. To obtain the diamond growth temperature,
the tungsten substrates were positioned 8–10mm from the hot
filament.
After CVD boron-doped diamond deposition, the coated
tungsten wires were subjected to low pressure polymerization,
resulting in a ∼30µm coating of parylene-C. This material
provided enhanced biocompatibility as well as providing
an insulating coating along the shaft of the electrode.
Since the parylene uniformly coats the entire electrode
during deposition, the first ∼100µm of the electrode tip’s
boron-doped diamond coating is subsequently exposed
by selectively ablating the parylene coating using a pulsed
ultraviolet laser (Photomachining, Inc. of Pelham, NH).
The electrode was inserted into an outer cannula (FHC,
Inc. Bowdoin, ME) that served as a stainless steel reference
electrode.
For comparison, a CFM was fabricated by attaching a single
polyacrylonitrile-based carbon fiber (7µm in diameter; Cytec,
Woodland Park, NJ) to a Nitinol (an alloy of nickel and titanium)
extension wire with a silver-based conductive adhesive. The
connection between the carbon fiber and the Nitinol wire was
covered with cured polyamic acid (polyamide). The exposed
carbon fiber was trimmed under a dissecting microscope to
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a length of 50–100µm. The details of CFM production are
discussed by Chang et al. (2012a).
Electrode Characterization
Surface morphology and microstructure of the boron-doped
diamond electrode and CFM were imaged with a SEM (Hitachi
S4700 Field Emission SEM) under conditions of 1.0 kV
accelerating voltage and 10µA beam current.
The confocal Raman measurements were acquired using an
alpha 300R WITec system (Ulm, Germany) equipped with a
UHTS300 spectrometer and a thermoelectrically cooled DV40-
11 CCD detector. A frequency-doubled Nd:YAG laser at 532 nm
was used for excitation. The samples were mounted on a
piezoelectric, computer-controlled stage, with the film normal to
the incident laser beam. Tominimize the optical effects occurring
from the inherent curvature of the tungsten rods, a Nikon 20x
objective was employed.
The chemical morphology of diamond films was explored
by 2-D surface confocal Raman mapping. To generate these
Raman mapping images of 100 × 100µm dimensions, a Raman
spectrum was recorded at every image pixel, for a total of more
than 100,000 spectra. Mappings of material constituents, namely
diamond, boron, and sp2 type of carbon impurities, were first
obtained using filters for their characteristic Raman vibrations
at 1332 cm−1, centered around 550 and 1500 cm−1, respectively.
The visual correlation of the spatial distribution of the above-
mentioned constituents was accomplished by false coloring them
with red (for diamond), blue (for boron), and green (for carbon
impurities), and by merging these independent maps. To reduce
the background noise, the intensity threshold for diamond,
boron and non-diamond carbon peaks included in mapping was
appropriately adjusted.
Wireless Instantaneous Neurochemical
Concentration Sensing (WINCS) System
FSCV detection of dopamine was achieved using WINCS.
Briefly, WINCS hardware incorporates front-end analog
transimpedance amplifier circuitry, a Bluetooth transceiver
and a microcontroller—all integrated with a multilayer printed
wiring board (PWB). The microcontroller produces an FSCV
waveform applied to the electrochemical sensors, digitizes
the nanoampere level electrochemical signal after current-
voltage conversion by the transimpedance amplifier and
controls the flow of data to the base station. Digital telemetry
between the remote WINCS unit and base station is achieved
by an embedded Bluetooth transceiver. WINCS software,
“WincsWare,” (Mayo Clinic, Division of Engineering) controls
the scan parameters and operation of WINCS, such as starting
and stopping data acquisition and transmission, modifying
FSCV waveform, changing sampling rate, and nearly real-time
saving, conditioning, and displaying transmitted data.
Flow Injection Analyses of Dopamine
Both diamond and CFMs were calibrated with a custom designed
flow cell. A FIAlab 3200 injection system (FIAlab Instruments,
Seattle, WA) was utilized to introduce Tris buffer and dopamine
sequentially to the sensing electrode. Dopamine samples with
concentration ranging from 0.5 to 10µM were used for
calibration and were prepared by diluting 5mM stock solution in
Tris buffer. A triangular waveform was generated byWincsWare,
with the potential ramped from −0.4 to +1.5V and back at a
scan rate of 400V/s. This waveform was continually applied to
the electrode at 10Hz. Ag/AgCl served as the reference electrode.
For each dopamine sample, five injections were attempted. The
cyclic voltammograms prior to and after each injection were
collected and subtracted from each other to obtain the cyclic
voltammogram of dopamine. The oxidation peak currents for
those injections were then averaged for calibration.
To evaluate their long term durability, both diamond
microelectrode and CFMs were continually subjected to the
triangular waveform described above at 10Hz for 144 h.
Dopamine calibrations were taken prior to 72 h and after 144 h
of waveform application.
In vivo Neurotransmitter Measurement
Consent Process to Recruit Participants
The research protocol was approved by Mayo Clinic IRB
(Institutional Review Board, protocol #09-007441). Outpatients
in our neurosurgery clinic were given the opportunity to consent
to the study before surgery. A mandatory waiting period of one
night prior to their scheduled surgery was instituted to allow
patients to withdraw if they elected to do so. The following was
ensured:
1. Participants can knowledgeably discuss the consent document
with their physician (assure understanding) and whomever
else they turn to for advice (e.g., family members).
2. Participants understand that no services, treatments, or
benefits will be withheld if they do not participate in the
research. They also understand that their consent to the study
will not directly benefit them.
Deep Brain Stimulation (DBS) Surgery Protocol
Inclusion/Exclusion Criteria
Inclusion
Adult patients with medically intractable essential tremor or
Parkinson’s disease who have been approved for DBS surgery by
the interdisciplinary Mayo DBS committee.
Exclusion
Pregnant patients, prisoners, children (under 18 years of age),
and any patients identified by the Mayo Clinic DBS committee
as unsuitable for the study protocol.
DBS Neurosurgery in Human Subjects
These studies were approved by Mayo Clinic IRB (IRB #09-
007441) and registered with ClinicalTrials.gov (Clinical trials #
NCT01705301). Written informed consent was obtained from
all patients prior to surgery. Under local anesthesia, an MRI-
compatible stereotactic head frame was fixed to the patient’s
head. A localizer box created nine fiducials as reference points
to enable localization of MR images in stereotactic space. The
patient was then transported to the MRI scanner. MR imaging
was conducted using a General Electric Sigma 1.5 T MRI
clinical system operated by EchoSpeed LX Version 9.1. The
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human DBS imaging protocol consists of MP-RAGE sequences
using 1.5mm slice thickness and 24 cm field of view. Using
COMPASS navigational software, MRI data were merged with
the human Schaltenbrand and Wahren stereotactic atlas, and
stereotactic coordinates for DBS electrode implantation were
identified. The patient was then returned to the operating suite
where, under local anesthesia, a skin incision in line with the
trajectory coordinates was made followed by a 5–10mm burr
hole made in the skull using a high-speed drill. Microelectrodes
for standard electrophysiological recording and for the FSCV
recording using a sensing probe, called a “WincsTrode,” were
implanted simultaneously through 5-trajectory guide cannula
system that was attached to the Alpha Omega microdrive system.
As cellular activities were measured through the center trajectory
to define the target, FSCV recordings were performed in a
2mm anterior path from the center of the 5-trajectory guide
cannula system. Once brainmapping was successfully performed,
the electrophysiological recording electrode was replaced with
the DBS electrode. Electrochemical recordings utilizing the
WincsTrode were obtained to evaluate the concomitant changes
in neurochemical extracellular levels.
To document potential microthalamotomy effects, the
frequency and amplitude of hand tremor were recorded
using a wireless accelerometer which was affixed to patients’
wrists during surgery. To obtain a baseline, accelerometer
recordings were made 20 s before DBS electrode implantation.
During this DBS surgery in the operation room, FSCV
recordings were performed using the WINCS system. There
were no complications following DBS surgery and concurrent
electrochemical recordings.
Fast Scan Cyclic Voltammetry (FSCV) Recording in
Humans
To perform FSCV recording, WINCS and WincsWare were
utilized. For FSCV, the potential at the electrode was linearly
scanned at 400V/s in a triangular waveform from –0.4 to 1.5V
and back to –0.4V at 10Hz for co-monitoring, when present,
adenosine and dopamine. The electrode rests at a bias potential
of−0.4V between scans.
Electrode and WINCS Sterilization
Prior to implantation in patients, every effort was made to ensure
safe and sterile implantation. WINCS units were sterilized by the
Sterrad R© hydrogen peroxide gas plasma process. Electrodes and
accessory wires were sterilized with an ethylene oxide treatment.
Ethylene oxide, the most common chemical sterilization method,
is used for over 70% of all sterilizations and for 50% of all
disposable medical devices. Ethylene oxide treatment was carried
out for 24 h at 60◦C with relative humidity above 30% and a gas
concentration of 200 mg/l. This process was followed by a 72 h
decay period in which the sterilized electrodes were quarantined.
Because the pre- and post-sterilization calibrations were nearly
identical, it appeared that the ethylene oxide sterilization did not
affect the structure and characteristics of either the diamond or
carbon fiber-based FSCV electrodes.
AUTHOR CONTRIBUTIONS
KB contributed the initial concept of boron-doped diamond
electrodes for human neurochemical detection, developed the
diamond reactor, conceived project, critically revisedmanuscript,
conceived Raman analysis procedure, and interpreted data.
JT drafted and critically revised the manuscript, developed
experimental design, and analyzed data. HM developed, analyzed
and interpreted human FSCV data. FM developed the Raman
analysis, interpreted the data, and drafted the Raman section of
manuscript. MM fabricated electrodes, and analyzed longevity
data. SP collected and analyzed animal and human studies data.
MS operated the reactor, fabricated electrodes, and analyzed
production data. EN collected and evaluated animal studies
data. CB reviewed and critically revised the manuscript. AK
provided critical revisions and interpretation of Raman data.
SC developed, analyzed, and interpreted animal FSCV data. KL
performed human surgeries, conceived of the application in
humans, and drafted and revised the human section. The authors
declare no competing financial interests.
ACKNOWLEDGMENTS
This work was made possible by the generous support of The
Grainger Foundation, NIH awards R01 NS075013, NIH grant
R01 NS070872, and U01 NS090455, and by a research agreement
between the University of Texas at El Paso and the Mayo Clinic.
The chemical vapor deposition diamond reactor was designed
and constructed by the Division of Engineering staff at Mayo
Clinic.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: http://journal.frontiersin.org/article/10.3389/fnhum.
2016.00102
REFERENCES
Adams, K. L., Puchades, M., and Ewing, A. G. (2008). In vitro
electrochemistry of biological systems. Annu. Rev. Anal. Chem. 1, 329.
doi: 10.1146/annurev.anchem.1.031207.113038
Agnesi, F., Tye, S. J., Bledsoe, J. M., Griessenauer, C. J., Kimble, C. J., Sieck,
G. C., et al. (2009). Wireless Instantaneous Neurotransmitter Concentration
System-based amperometric detection of dopamine, adenosine, and glutamate
for intraoperative neurochemical monitoring. J. Neurosurg. 111, 701–711. doi:
10.3171/2009.3.JNS0990
Bekar, L., Libionka, W., Tian, G. F., Xu, Q., Torres, A., Wang, X., et al. (2008).
Adenosine is crucial for deep brain stimulation-mediated attenuation of
tremor. Nat. Med. 14, 75–80. doi: 10.1038/nm1693
Bernard, M., Baron, C., and Deneuville, A. (2004). About the origin of the
low wave number structures of the Raman spectra of heavily boron doped
diamond films. Diam. Relat. Mater. 13, 896–899. doi: 10.1016/j.diamond.2003.
11.082
Bitziou, E., O’Hare, D., and Patel, B. A. (2008). Simultaneous detection of pH
changes and histamine release from oxyntic glands in isolated stomach. Anal.
Chem. 80, 8733–8740. doi: 10.1021/ac801413b
Frontiers in Human Neuroscience | www.frontiersin.org 10 March 2016 | Volume 10 | Article 102
Bennet et al. A Diamond-Based Electrode for Human Use
Bledsoe, J. M., Kimble, C. J., Covey, D. P., Blaha, C. D., Agnesi, F.,
Mohseni, P., et al. (2009). Development of the Wireless Instantaneous
Neurotransmitter Concentration System for intraoperative neurochemical
monitoring using fast-scan cyclic voltammetry. J. Neurosurg. 111, 712–723. doi:
10.3171/2009.3.JNS081348
Burns, R. S., LeWitt, P. A., Ebert, M. H., Pakkenberg, H., and Kopin, I. J. (1985).
The clinical syndrome of striatal dopamine deficiency. Parkinsonism induced
by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).N. Engl. J. Med. 312,
1418–1421. doi: 10.1056/NEJM198505303122203
Cahill, P. S., Walker, Q. D., Finnegan, J. M., Mickelson, G. E., Travis, E.
R., and Wightman, R. M. (1996). Microelectrodes for the measurement
of catecholamines in biological systems. Anal. Chem. 68, 3180–3186. doi:
10.1021/ac960347d
Chan, H. Y., Aslam, D. M., Wiler, J. A., and Casey, B. (2009). A novel diamond
microprobe for neuro-chemical and -electrical recording in neural prosthesis.
J. Microelectromech. Syst. 18, 511–521. doi: 10.1109/JMEMS.2009.2015493
Chang, S. Y., Jay, T., Munoz, J., Kim, I., and Lee, K. H. (2012a). Wireless fast-
scan cyclic voltammetry measurement of histamine using WINCS–a proof-of-
principle study. Analyst 137, 2158–2165. doi: 10.1039/c2an16038b
Chang, S. Y., Kim, I., Marsh, M. P., Jang, D. P., Hwang, S. C., Van Gompel, J. J.,
et al. (2012b). Wireless fast-scan cyclic voltammetry to monitor adenosine in
patients with essential tremor during deep brain stimulation. Mayo Clin. Proc.
87, 760–765. doi: 10.1016/j.mayocp.2012.05.006
Cragg, S. J., Hille, C. J., and Greenfield, S. A. (2000). Dopamine release and
uptake dynamics within nonhuman primate striatum in vitro. J. Neurosci. 20,
8209–8217.
Dommett, E., Coizet, V., Blaha, C. D., Martindale, J., Lefebvre, V., Walton, N.,
et al. (2005). How visual stimuli activate dopaminergic neurons at short latency.
Science 307, 1476–1479. doi: 10.1126/science.1107026
Garris, P. A., Kilpatrick, M., Bunin, M. A., Michael, D., Walker, Q. D.,
and Wightman, R. M. (1999). Dissociation of dopamine release in the
nucleus accumbens from intracranial self-stimulation. Nature 398, 67–69. doi:
10.1038/18019
Halpern, J. M., Xie, S. T., Sutton, G. P., Higashikubo, B. T., Chestek,
C. A., Lu, H., et al. (2006). Diamond electrodes for neurodynamic
studies in Aplysia californica. Diam. Relat. Mater. 15, 183–187. doi:
10.1016/j.diamond.2005.06.039
Hashemi, P., Dankoski, E. C., Petrovic, J., Keithley, R. B., and Wightman, R. M.
(2009). Voltammetric detection of 5-hydroxytryptamine release in the rat brain.
Anal. Chem. 81, 9462–9471. doi: 10.1021/ac9018846
Keithley, R. B., Takmakov, P., Bucher, E. S., Belle, A. M., Owesson-White, C. A.,
Park, J., et al. (2011). Higher sensitivity dopamine measurements with faster-
scan cyclic voltammetry. Anal. Chem. 83, 3563–3571. doi: 10.1021/ac200143v
Lee, K. H., Blaha, C. D., Garris, P. A., Mohseni, P., Horne, A. E., Bennet, K. E.,
et al. (2009). Evolution of deep brain stimulation: human electrometer and
smart devices supporting the next generation of therapy. Neuromodulation 12,
85–103. doi: 10.1111/j.1525-1403.2009.00199.x
Lee, K. H., Blaha, C. D., Harris, B. T., Cooper, S., Hitti, F. L., Leiter, J. C., et al.
(2006). Dopamine eﬄux in the rat striatum evoked by electrical stimulation of
the subthalamic nucleus: potential mechanism of action in Parkinson’s disease.
Eur. J. Neurosci. 23, 1005–1014. doi: 10.1111/j.1460-9568.2006.04638.x
Lee, K. H., Chang, S. Y., Roberts, D. W., and Kim, U. (2004). Neurotransmitter
release from high-frequency stimulation of the subthalamic nucleus.
J. Neurosurg. 101, 511–517. doi: 10.3171/jns.2004.101.3.0511
Lee, K. H., Kristic, K., van Hoff, R., Hitti, F. L., Blaha, C., Harris, B., et al. (2007).
High-frequency stimulation of the subthalamic nucleus increases glutamate
in the subthalamic nucleus of rats as demonstrated by in vivo enzyme-
linked glutamate sensor. Brain Res. 1162, 121–129. doi: 10.1016/j.brainres.2007.
06.021
Marcelli, G., and Patel, B. A. (2010). Understanding changes in uptake and
release of serotonin from gastrointestinal tissue using a novel electroanalytical
approach. Analyst 135, 2340–2347. doi: 10.1039/c0an00260g
McCreery, D. B., Agnew,W. F., Yuen, T. G., and Bullara, L. A. (1995). Relationship
between stimulus amplitude, stimulus frequency and neural damage during
electrical stimulation of sciatic nerve of cat.Med. Biol. Eng. Comput. 33(3 Spec
No), 426–429. doi: 10.1007/BF02510526
Meng, H. M., Wang, Y. A., Huang, M., Lin, W. H., Wang, S., and Zhang,
B. M. (2011). Chronic deep brain stimulation of the lateral habenula
nucleus in a rat model of depression. Brain Res. 1422, 32–38. doi:
10.1016/j.brainres.2011.08.041
Navailles, S., Benazzouz, A., Bioulac, B., Gross, C., and De Deurwaerdere, P.
(2010). High-frequency stimulation of the subthalamic nucleus and L-3,4-
dihydroxyphenylalanine inhibit in vivo serotonin release in the prefrontal
cortex and hippocampus in a rat model of Parkinson’s disease. J. Neurosci. 30,
2356–2364. doi: 10.1523/JNEUROSCI.5031-09.2010
Park, J., Show, Y., Quaiserova, V., Galligan, J. J., Fink, G. D., and
Swain, G. M. (2005). Diamond microelectrodes for use in biological
environments. J. Electroanal. Chem. (Lausanne. Switz.) 583, 56–68. doi:
10.1016/j.jelechem.2005.04.032
Patel, B. A., Bian, X. H., Quaiserova-Mocko, V., Galligan, J. J., and Swain, G. M.
(2007). In vitro continuous amperometric monitoring of 5-hydroxytryptamine
release from enterochromaffin cells of the guinea pig ileum.Analyst 132, 41–47.
doi: 10.1039/B611920D
Phillips, P. E. M., Stuber, G. D., Heien, M. L. A. V., Wightman, R. M., and Carelli,
R. M. (2003). Subsecond dopamine release promotes cocaine seeking. Nature
422, 614–618. doi: 10.1038/nature01476
Rice, M. E., Cragg, S. J., and Greenfield, S. A. (1997). Characteristics of electrically
evoked somatodendritic dopamine release in substantia nigra and ventral
tegmental area in vitro. J. Neurophysiol. 77, 853–862.
Roberts, J. G., Moody, B. P., McCarty, G. S., and Sombers, L. A. (2010).
Specific oxygen-containing functional groups on the carbon surface underlie an
enhanced sensitivity to dopamine at electrochemically pretreated carbon fiber
microelectrodes. Langmuir 26, 9116–9122. doi: 10.1021/la9048924
Robinson, D. L., Venton, B. J., Heien, M. L., and Wightman, R. M. (2003).
Detecting subsecond dopamine release with fast-scan cyclic voltammetry
in vivo. Clin. Chem. 49, 1763–1773. doi: 10.1373/49.10.1763
Runnels, P. L., Joseph, J. D., Logman, M. J., and Wightman, R. M. (1999). Effect
of pH and surface functionalities on the cyclic voltammetric responses of
carbon-fiber microelectrodes. Anal. Chem. 71, 2782–2789. doi: 10.1021/ac9
81279t
Sanchez-Gonzalez, M. A., Garcia-Cabezas, M. A., Rico, B., and Cavada, C. (2005).
The primate thalamus is a key target for brain dopamine. J. Neurosci. 25,
6076–6083. doi: 10.1523/JNEUROSCI.0968-05.2005
Sarter, M., Bruno, J. P., and Parikh, V. (2007). Abnormal neurotransmitter release
underlying behavioral and cognitive disorders: toward concepts of dynamic and
function-specific dysregulation. Neuropsychopharmacology 32, 1452–1461. doi:
10.1038/sj.npp.1301285
Shon, Y. M., Chang, S. Y., Tye, S. J., Kimble, C. J., Bennet, K. E., Blaha,
C. D., et al. (2010a). Comonitoring of adenosine and dopamine using
the Wireless Instantaneous Neurotransmitter Concentration System:
proof of principle. J. Neurosurg. 112, 539–548. doi: 10.3171/2009.7.
JNS09787
Shon, Y. M., Lee, K. H., Goerss, S. J., Kim, I. Y., Kimble, C., Van Gompel,
J. J., et al. (2010b). High frequency stimulation of the subthalamic nucleus
evokes striatal dopamine release in a large animal model of human
DBS neurosurgery. Neurosci. Lett. 475, 136–140. doi: 10.1016/j.neulet.2010.
03.060
Singh, Y. S., Sawarynski, L. E., Michael, H. M., Ferrell, R. E., Murphey-Corb, M.
A., Swain, G. M., et al. (2010). Boron-doped diamond microelectrodes reveal
reduced serotonin uptake rates in lymphocytes from adult rhesus monkeys
carrying the short allele of the 5-HTTLPR. ACS Chem. Neurosci. 1, 49–64. doi:
10.1021/cn900012y
Staal, R. G., Mosharov, E. V., and Sulzer, D. (2004). Dopamine neurons release
transmitter via a flickering fusion pore. Nat. Neurosci. 7, 341–346. doi:
10.1038/nn1205
Suaud-Chagny, M. F. (2004). In vivo monitoring of dopamine overflow in
the central nervous system by amperometric techniques combined with
carbon fibre electrodes. Methods 33, 322–329. doi: 10.1016/j.ymeth.2004.
01.009
Suzuki, A., Ivandini, T. A., Yoshimi, K., Fujishima, A., Oyama, G., Nakazato, T.,
et al. (2007). Fabrication, characterization, and application of boron-doped
diamond microelectrodes for in vivo dopamine detection. Anal. Chem. 79,
8608–8615. doi: 10.1021/ac071519h
Swamy, B. E. K., and Venton, B. J. (2007). Subsecond detection of physiological
adenosine concentrations using fast-scan cyclic voltammetry. Anal. Chem. 79,
744–750. doi: 10.1021/ac061820i
Frontiers in Human Neuroscience | www.frontiersin.org 11 March 2016 | Volume 10 | Article 102
Bennet et al. A Diamond-Based Electrode for Human Use
Takmakov, P., Zachek, M. K., Keithley, R. B., Walsh, P. L., Donley, C., McCarty, G.
S., et al. (2010). CarbonMicroelectrodes with a Renewable Surface.Anal. Chem.
82, 2020–2028. doi: 10.1021/ac902753x
Wightman, R. M., and Robinson, D. L. (2002). Transient changes in mesolimbic
dopamine and their association with ‘reward’. J. Neurochem. 82, 721–735. doi:
10.1046/j.1471-4159.2002.01005.x
Xie, S. T., Shafer, G., Wilson, C. G., and Martin, H. B. (2006). In vitro adenosine
detection with a diamond-based sensor. Diam. Relat. Mater. 15, 225–228. doi:
10.1016/j.diamond.2005.08.018
Yoshimi, K., Naya, Y., Mitani, N., Kato, T., Inoue, M., Natori, S., et al.
(2011). Phasic reward responses in the monkey striatum as detected by
voltammetry with diamond microelectrodes. Neurosci. Res. 71, 49–62. doi:
10.1016/j.neures.2011.05.013
Zhao, H., Bian, X. C., Galligan, J. J., and Swain, G. M. (2010). Electrochemical
measurements of serotonin (5-HT) release from the guinea pig
mucosa using continuous amperometry with a boron-doped diamond
microelectrode. Diam. Relat. Mater. 19, 182–185. doi: 10.1016/j.diamond.2009.
10.004
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2016 Bennet, Tomshine, Min, Manciu, Marsh, Paek, Settell, Nicolai,
Blaha, Kouzani, Chang and Lee. This is an open-access article distributed under the
terms of the Creative Commons Attribution License (CC BY). The use, distribution or
reproduction in other forums is permitted, provided the original author(s) or licensor
are credited and that the original publication in this journal is cited, in accordance
with accepted academic practice. No use, distribution or reproduction is permitted
which does not comply with these terms.
Frontiers in Human Neuroscience | www.frontiersin.org 12 March 2016 | Volume 10 | Article 102
